You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 3, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Swati Venkat1, Michael E Feigin1
1Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Alternative polyadenylation in 3' untranslated regions (3' UTR-APA) drives tumor cell heterogeneity. This mechanism influences gene expression, impacting cancer progression and cell states in pancreatic ductal adenocarcinoma (PDAC).
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: